Table 1.
Mechanism of action | Drug | Genotype |
Protease inhibitor | Telaprevir | 1 |
Boceprevir | 1 | |
Simeprevir | 1 | |
Paritaprevir | 1, 4 | |
Grazoprevir | 1, 4 | |
Asunaprevir1 | 1 | |
ABT-4501 | 1 | |
Faldaprevir1 | 1 | |
NS5A inhibitors | Daclatasvir | 1, 3 |
Ombitasvir | 1, 4 | |
Ledipasvir | 1, 4, 5, 6 | |
Elbasvir | 1, 4 | |
Velpatasvir1 | 4 | |
NS5B inhibitors | ||
Nucleotide-analogue | Sofosbuvir | 1, 2, 3, 4, 5, 6 |
Non-nucleoside analogue | Dasabuvir | 1 |
Beclabuvir1 | 1 |
Non-FDA approved drugs.